Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

- YORVIPATH (developed as TransCon PTH) is a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism - Ascendis plans its first EU launch of ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor ...

RIYADH, Saudi Arabia, Aug. 27, 2025 /PRNewswire/ -- MS Pharma has officially inaugurated the first biologics' manufacturing facility in the Middle East, strategically located in Saudi Arabia. The ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

The New York Islanders today announced a multi-year agreement with Vanda Pharmaceuticals, a global biopharmaceutical company, ...

Elizabeth Holmes, in dark outfit, arrived Tuesday at federal court in San Jose, Ca., for a day of cross-examination by the prosecution in her criminal-fraud trial. (David Paul Morris/Bloomberg News) ...

LEOBENDORF, Austria and TORONTO, Oct. 10, 2025 /CNW/ — Croma-Pharma GmbH, a global leader in minimally invasive aesthetic ...

COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday ...

COPENHAGEN, Denmark, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the 2025 Wells Fargo Healthcare ...

Ascendis Pharma announced positive results from the Week 26 analysis of its Phase 2 trial, New InsiGHTS, which studied once-weekly TransCon hGH for prepubertal children with Turner syndrome. The trial ...